Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/16787

Title: Historical epidemiology of hepatitis C virus (HCV) in selected countries
Authors: Bruggmann, P.
Berg, T.
Ovrehus, A. L. H.
Moreno, C.
Brandao Mello, C. E.
Roudot-Thoraval, F.
Marinho, R. T.
Sherman, M.
Ryder, S. D.
Sperl, J.
Akarca, U.
Balik, I.
Bihl, F.
Bilodeau, M.
Blasco, A. J.
Buti, M.
Calinas, F.
Calleja, J. L.
Cheinquer, H.
Christensen, P. B.
Clausen, M.
Coelho, H. S. M.
Cornberg, M.
Cramp, M. E.
Dore, G. J.
Doss, W.
Duberg, A. S.
El-Sayed, M. H.
Ergor, G.
Esmat, G.
Estes, C.
Falconer, K.
Felix, J.
Ferraz, M. L. G.
Ferreira, P. R.
Frankova, S.
Garcia-Samaniego, J.
Gerstoft, J.
Giria, J. A.
Goncales, F. L., Jr.
Gower, E.
Gschwantler, M.
Guimaraes Pessoa, M.
Hezode, C.
Hofer, H.
Husa, P.
Idilman, R.
Kaberg, M.
Kaita, K. D. E.
Kautz, A.
Kaymakoglu, S.
Krajden, M.
Krarup, H.
Laleman, W.
Lavanchy, D.
Lazaro, P.
Marotta, P.
Mauss, Stefan
Mendes Correa, M. C.
Muellhaupt, B.
Myers, R. P.
Negro, F.
Nemecek, V.
Ormeci, N.
Parkes, J.
Peltekian, K. M.
Ramji, A.
Razavi, H.
Reis, N.
Roberts, S. K.
Rosenberg, W. M.
Sarmento-Castro, R.
Sarrazin, C.
Semela, D.
Shiha, G. E.
Sievert, W.
Starkel, P.
Stauber, R. E.
Thompson, A. J.
Urbanek, P.
van Thiel, I.
Van Vlierberghe, H.
VANDIJCK, Dominique
Vogel, W.
Waked, I.
Wedemeyer, H.
Weis, N.
Wiegand, J.
Yosry, A.
Zekry, A.
Van Damme, P.
Aleman, S.
Hindman, S. J.
Issue Date: 2014
Citation: JOURNAL OF VIRAL HEPATITIS, 21 (S1), p. 5-33
Abstract: Chronic infection with hepatitis C virus (HCV) is a leading indicator for liver disease. New treatment options are becoming available, and there is a need to characterize the epidemiology and disease burden of HCV. Data for prevalence, viremia, genotype, diagnosis and treatment were obtained through literature searches and expert consensus for 16 countries. For some countries, data from centralized registries were used to estimate diagnosis and treatment rates. Data for the number of liver transplants and the proportion attributable to HCV were obtained from centralized databases. Viremic prevalence estimates varied widely between countries, ranging from 0.3% in Austria, England and Germany to 8.5% in Egypt. The largest viremic populations were in Egypt, with 6 358 000 cases in 2008 and Brazil with 2 106 000 cases in 2007. The age distribution of cases differed between countries. In most countries, prevalence rates were higher among males, reflecting higher rates of injection drug use. Diagnosis, treatment and transplant levels also differed considerably between countries. Reliable estimates characterizing HCV-infected populations are critical for addressing HCV-related morbidity and mortality. There is a need to quantify the burden of chronic HCV infection at the national level.
Notes: Bruggmann, P (reprint author), Arud Ctr Addict Med, Konradstr 32g, CH-8005 Zurich, Switzerland. p.bruggmann@arud.ch
URI: http://hdl.handle.net/1942/16787
DOI: 10.1111/jvh.12247
ISI #: 000333893200002
ISSN: 1352-0504
Category: A1
Type: Journal Contribution
Validation: ecoom, 2015
Appears in Collections: Research publications

Files in This Item:

Description SizeFormat
published version2.09 MBAdobe PDF

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.